7356-52-7

Basic information

• Product Name: 2-NITRO-3-ACETYLAMINO-4-METHYLBENZOIC ACID
• Synonyms: 2-NITRO-3-ACETYLAMINO-4-METHYLBENZOIC ACID;3-Acetamido-4-methyl-2-nitrobenzoic acid;Benzoic acid, 3-(acetylaMino)-4-Methyl-2-nitro-;3-Acetylamino-4-methyl-2-nitro-benzoic acid
• CAS NO: 7356-52-7
• Molecular Formula: C₁₀H₁₀N₂O₅
• Molecular Weight: 238.2
• Mol File: 7356-52-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 489.4°C at 760 mmHg
• Flash Point: 249.8°C
• Appearance: /
• Density: 1.459g/cm³
• Vapor Pressure: 2.15E-10mmHg at 25°C
• Refractive Index: 1.64
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-NITRO-3-ACETYLAMINO-4-METHYLBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-NITRO-3-ACETYLAMINO-4-METHYLBENZOIC ACID(7356-52-7)
• EPA Substance Registry System: 2-NITRO-3-ACETYLAMINO-4-METHYLBENZOIC ACID(7356-52-7)

Safety Data

• Hazardous Substances Data: 7356-52-7(Hazardous Substances Data)

Usage

General Description

2-Nitro-3-acetylamino-4-methylbenzoic acid is an organic compound with the chemical formula C10H10N2O5. It is a derivative of benzoic acid, containing a nitro group, an acetyl group, and an amino group on the benzene ring. 2-NITRO-3-ACETYLAMINO-4-METHYLBENZOIC ACID is commonly used in the synthesis of various pharmaceuticals and dyes. It has been studied for its potential pharmacological properties, including its antibacterial and anti-inflammatory effects. Additionally, it has been investigated as an intermediate in the production of other organic compounds. As with any chemical compound, it should be handled and used with appropriate caution and under the guidance of a trained professional.

InChI:InChI=1/C10H10N2O5/c1-5-3-4-7(10(14)15)9(12(16)17)8(5)11-6(2)13/h3-4H,1-2H3,(H,11,13)(H,14,15)

Upstream product

• 6946-14-1 3-acetylamino-4-methylbenzoic acid 
• 2458-12-0 3-amino-p-toluic acid 

Downstream Products

• 6946-15-2 3-hydroxy-4-methyl-2-nitro-benzoic acid 
• 20587-29-5 methyl 4-methyl-2-nitrobenzoate 
• 320740-34-9 methyl 2-amino-3-bromo-4-methylbenzoate 
• 320740-35-0 2-amino-3-bromo-4-methylbenzoic acid 
• 320740-33-8 methyl 3-bromo-4-methyl-2-nitrobenzoate 
• 320740-32-7 3-bromo-4-methyl-2-nitrobenzoic acid 
• 37901-90-9 3-amino-4-methyl-2-nitrobenzoic acid 

Relevant articles and documents

COVALENT INHIBITORS OF KRAS

Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R1, R2a,

NITROGEN-CONTAINING BICYCLIC HETEROARYL COMPOUNDS AND METHODS OF USE

The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have Formula (I) wherein R1 is Formula (II), (III) or (IV) and A1, A2, A3, A4, X, Z, Z', R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.

Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form

6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated di